Curanex Pharmaceuticals Inc Common Stock

CURXNASDAQ • USD
ThemeBiotech - Drug Development›Metabolic & Cardiometabolic
4.24 USD
↘ 0.05 (1.26%)🟢LIVE (AS OF 03:22 PM EDT)
🟢Market: OPEN

Curanex Pharmaceuticals Inc Common Stock (CURX) is currently trading at $4.24. Technicals currently rate "Strong Sell" while our fundamental analysis reads "Neutral". This is driven by a robust Altman Z-Score, a weak Piotroski F-Score of 0/9, negative Return on Equity and a bearish Death Cross on the long-term moving averages. Valuation metrics suggest CURX is trading at a discount to its peers, earning an "Attractively Valued" rating.

Technical & fundamental data as of Sep 15, 2026.

Open?$4.21
High?$4.44
Low?$4.14
Prev. Close?$4.29
Volume?7.3K
Avg. Volume?133.1K
VWAP?$4.26
Rel. Volume?0.05x
Bid / Ask
Bid?$3.61 × 100
Ask?$5.00 × 100
Spread?$1.39
Midpoint?$4.31
Valuation & Ratios
Market Cap?6.7M
Shares Out?1.6M
Float?9.1M
Float %?32.2%
P/E Ratio?N/A
P/B Ratio?1.41
EPS?-$6.68
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Curanex Pharmaceuticals Inc is engaged in discovering, developing, and commercializing botanical drugs for treating unmet medical needs in patients with inflammatory disease. Its compound, Phyto-N, is in preclinical research for six indications: ulcerative colitis, atopic dermatitis, COVID-19, type 2 diabetes, nonalcoholic fatty liver disease (NAFLD) and gout. Phyto-N, is a proprietary botanical extract with chemical components and pharmacological activities that harnesses potential anti-inflammatory properties of a medicinal plant.
Themes
Biotech - Drug Development›Metabolic & CardiometabolicBiotech - Drug Development›Immunology & Autoimmune
Employees
6
Market Cap
6.7M
Industry
PHARMACEUTICAL PREPARATIONS
Website
www.curanexpharma.com
Listed
2025-08-26
Address
2 JERICHO PLAZA,
JERICHO, NY 11753
Phone: 718-673-6078
Technical OutlookStrong Sell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-3/3)
Medium-Term (Wave)?▼ Bearish(-3/3)
Short-Term (Ripple)?▼ Bearish(-3/3)
MA Alignment?Mixed
Full Technical Analysis →
Fundamental OutlookNeutral
Strong SellNeutralStrong Buy
F-Score?
3
Z-Score?
99
Momentum?
50
Short Sent.?
80
Piotroski F-Score?0/9Weak
Altman Z-Score?5.23Safe
Confidence?23%Very Low
Full Fundamental Analysis →
Short InterestLow
Short % of Float?0.00%Low
Short Interest?449
Days to Cover?1.0
Free Float9.1M
Avg Daily Volume35.0K
Settlement Date2026-08-31
Financial Health
Current Ratio?45.95Strong
Quick Ratio?45.95Strong
Cash Ratio?28.17Strong
Debt/Equity?0.00Low
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score
100/100
P/E?
N/A▾
P/B?
Peers
100
S&P
89
1.41CHEAP▾
P/S?
N/A▾
P/FCF?
N/A▾
EV/EBITDA?
S&P
97
-0.4CHEAP▾
EV/Sales?
N/A▾
Returns & Efficiency
ROE?
S&P
3
-218.7%WEAK▾
ROA?
S&P
3
-206.3%WEAK▾
Cash Flow & Enterprise
FCF?$-12079094
Enterprise Value?$3.8M
Fundamentals ratios updated end of day
MarketsMoversWatchlist